IP Library › Assignment 025619/0489
Patent Assignment
Reel/Frame 025619/0489

Merger

Recorded: 2011-01-11 Pages: 112
Assignor
BAYER HEALTHCARE AG
Executed: 2008-12-04
Assignee
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
MUELLERSTRASSE 178, BERLIN, 13353, GERMANY
Covered Properties (3)
Substituted Thieno[3,2-D]Pyrimidines as Rho Kinase Inhibitors
Patent: 7,648,986 →
Application: 11/733,045 →
Publication: US 2007/0238741
Diaryl Ureas for Treating Virus Infections
Application: 12/097,350 →
Publication: US 2009/0227637
Substituted Pyrimidine Derivatives Useful in the Treatment of Cancer and Other Disorders
Patent: 8,580,798 →
Application: 12/158,524 →
Publication: US 2010/0081812
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 3, 2008
From: WEBER, OLAF; RIEDL, BERND
To: BAYER HEALTHCARE AG
Reel/Frame 021776/0478 →
Assignment of Assignor's Interest Jul 27, 2009
From: BAYER PHARMACEUTICALS CORPORATION
To: BAYER HEALTHCARE LLC
Reel/Frame 023027/0804 →
Assignment of Assignor's Interest Sep 22, 2009
From: SMITH, ROGER; DUMAS, JACQUES; WANG, GAN; LEE, WENDY
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023264/0721 →
Change of Name Nov 11, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 029277/0286 →
Change of Name Jul 1, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030719/0390 →